M. Iadanza

2-(Benzimidazol-2-yl)quinoxalines: a novel class of selective antagonists at human A(1) and A(3) adenosine receptors designed by 3D database searching.

E. Novellino, K. Klotz, B. Cosimelli, 2005, Journal of medicinal chemistry.

A1 adenosine receptor antagonists, 3‐aryl[1,2,4]triazino[4,3‐a]benzimidazol‐4‐(10H)‐ones (ATBIs) and N‐alkyl and N‐acyl‐(7‐substituted‐2‐phenylimidazo[1,2‐a][1,3,5]triazin‐4‐yl)amines (ITAs): Different recognition of bovine and human binding sites

Ettore Novellino, Sabrina Taliani, Federico Da Settimo, 2004 .

Synthesis of (+)- and (−)-cis-2-[(1-adamantylamino)-methyl]-1-phenylcyclopropane derivatives as high affinity probes for σ1 and σ2 binding sites

M. Iadanza, V. Pike, A. Marrazzo, 2002 .

New results on the reactivity of 5,6-diamino-4-hydroxy- 2-mercaptopyrimidine

E. Novellino, B. Cosimelli, M. Iadanza, 2004 .

New benzomorphan derivatives of MPCB as MOP and KOP receptor ligands.

M. Iadanza, C. Parenti, L. Pasquinucci, 2007, Pharmazie.

Design, synthesis and biological evaluation of novel N-alkyl- and N-acyl-(7-substituted-2-phenylimidazo[1,2-a][1,3,5]triazin-4-yl)amines (ITAs) as novel A(1) adenosine receptor antagonists.

E. Novellino, B. Cosimelli, G. Greco, 2002, Journal of medicinal chemistry.